Cannabis Investor Opportunistic LXIV Fund

 Prometheus Botany Medicinal

Operated by series LLC MKG Financial Group Private Equity Fund Adv.

Opportunistic investments LXIV Fund include investments in Licensed Cannabis tracked-and-trace Businesses (the debt instruments of companies which may be publicly traded or privately held that are Cannabis Dispensary, Cannabis Cultivation, Cannabis Manufacturing, Cannabis Distribution,  Cannabis Testing Laboratory, Facility, or Entity) and or Land Developmentmezzanine, secondaries, and other private investment strategies that are opportunistic in nature and do not follow a buyout or venture capital/growth equity strategy.

Typical holdings are senior and subordinated debt instruments and corporate bonds. Equity exposure is acceptable as debt positions are often converted to equity during the cultivation process. Investments are typically made in years one through five and returns typically occur in years three through ten. Investments may be made in companies that are either U.S. or non-U.S. domiciled.

htps:/mkgenterprisescorp-client.com/fund-of-funds-investing/

Investor will receive 15,625 shares of common stocks. Share prices are currently $0.16 each and requires a minimum investment of $2,500 to $5,000

Investment returns will fluctuate and are subject to market volatility, so that an investor’s shares, when redeemed or sold, may be worth more or less than their original cost. Unlike mutual funds, shares of  Prometheus Botany Medicinal operated by series LLC MKG Financial Group Private Equity Fund Advisors Private Placements are not individually redeemable directly with the exchange market NASDAQ, S&P 500, Down Jones, OTC Markets

Shares are bought and sold at par value, which may be higher or lower than the net asset value (NAV).

Equity Crowd Funding Offering Memorandum: Not FDIC Insured • No Bank Guarantee • May Lose Value

  • Cannabis Dispensary Investor Fund – Investment into a facility where cannabis or cannabis products, are offered, either individually or in combination, for retail sale, including an establishment that engages in delivery of cannabis or cannabis products as part of a retail sale.

 

  • Cannabis Cultivation Investor Fund– Investment into any activity involving the planting, growing, harvesting, drying, curing, grading, or trimming of cannabis. “Cultivation” also includes nurseries.

 

  • Cannabis Manufacturing Investor Fund – Investment into a LLC or Corporation  who conducts the production, preparation, propagation, or compounding of cannabis or cannabis products either directly or indirectly or by extraction methods, or independently by means of chemical synthesis, or by a combination of extraction and chemical synthesis, or that packages or repackages cannabis or cannabis products or labels or re-labels its container.

 

  • Cannabis Distribution Investor Fund– Investment into a LLC or Corporation engaged in procuring cannabis from a cultivator, and/or procuring cannabis products from a manufacturer, for sale to a licensed commercial cannabis business.

Cannabis Testing Investor Fund–   Investment into a laboratory, facility, or entity in the State, that offers or performs tests of cannabis or cannabis products and that is both of the following: 1) Accredited by an accrediting body that is independent from all other persons

 

City of Fresno | Draft Cannabis Regulations released by Council Sub-Committee

10 Cannabis license HUBS is expected to be issued November 2019

Draft Cannabis Regulations released by Council Sub-Committee

In the United States, to be considered an accredited investor, one must have a net worth of at least $1,000,000, excluding the value of one's primary residence, or have income at least $200,000 each year for the last two years (or $300,000 combined income if married) and have the expectation to make the same amount this year. The term "accredited investor" is defined in Rule 501 of Regulation D of the U.S. Securities and Exchange Commission (SEC) Dismiss

%d bloggers like this: